微针作为通过皮肤递送药物系统,用于增强皮肤疾病治疗
Chaoxiong Wu1, Qingyu Yu1, Chenlu Huang1
1State Key Laboratory of Advanced Medical Materials and Devices, Tianjin Key Laboratory of Biomedical Materials, Key Laboratory of Biomaterials and Nanotechnology for Cancer Immunotherapy, Institute of Biomedical Engineering, Tianjin Institutes of Health Science, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300192, China.
Acta pharmaceutica Sinica. B
|January 14, 2025
概括
微针在通过皮肤递送药物方面取得了突破,克服了皮肤障碍,改善了皮肤治疗. 进一步的研究和监管支持对于它们在治疗皮肤疾病中的广泛临床采用至关重要.
科学领域:
- 生物医学工程 生物医学工程
- 皮肤病学 皮肤病学
- 材料科学 材料科学 材料科学
背景情况:
- 传统的透皮药物输送因角层屏障而面临局限性.
- 微针 (MNs) 是一种创新的解决方案,可以提高药物透到皮肤.
- 本次审查侧重于MNs,以改善皮肤病理病理管理.
研究的目的:
- 审查微针在通过皮肤递送药物的各种类型和应用.
- 探索MNs在治疗各种皮肤病,包括癌症和炎症疾病方面的潜力.
- 确定MN疗法的临床和商业应用的挑战和前景.
主要方法:
- 审查关于微针技术和应用的现有文献.
- 分析不同的微针设计 (固体,涂层,空洞,水凝,可溶性).
- 检查MN在治疗皮肤癌症,炎症性皮肤病,伤口管理和美容皮肤病方面的作用.
主要成果:
- 微针有效地绕过角层,直接通过皮下递送药物.
- 各种MN类型在治疗皮肤疾病和化品配方中具有独特的应用.
- 显著的科学和商业挑战阻碍了广泛的临床采用.
结论:
- 微针具有革命性皮肤治疗和改善患者福利的巨大潜力.
- 克服剂量校准,生物相容性,制造和监管方面的挑战对于实现MN潜力至关重要.
- 持续的研究和创新对于微针技术的成功临床转化至关重要.
相关概念视频
Drug Delivery: Miscellaneous Routes
307
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
307
Drug Delivery: Overview
276
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
276
Non-Oral Extravascular Drug Absorption Routes
194
Non-oral extravascular routes, which encompass sublingual, buccal, topical, intramuscular, and inhalation methods, primarily utilize passive diffusion to transport drugs into the systemic circulation. The absorption rates and effectiveness of these routes depend on the drug's physicochemical properties, as well as the patient's anatomical and pathophysiological state.
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more...
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more...
194
Drug Delivery: Parenteral Route
402
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
402
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K


